PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmacokinetics and Monitored Therapy, Pomeranian Medical University in Szczecin, Poland.\', \'Department of Pathology, Pomeranian Medical University in Szczecin, Poland.\', \'Department of Anaesthesiology, Intensive Therapy and Acute Intoxications, Pomeranian Medical University in Szczecin, Poland.\', \'Department of Human Anatomy and Cell Science, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.\', \'Biotechnology Centre, Silesian University of Technology, Krzywoustego 8 Str., 44-100, Gliwice, Poland. Electronic address: mjelos@gmail.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1368-7646(20)30048-010.1016/j.drup.2020.100719
?:hasPublicationType
?:journal
  • Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
is ?:pmid of
?:pmid
?:pmid
  • 32717568
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32717568>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32717568>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all